Abstract:Polymyxin resistance principally arises from structural remodeling of bacterial surface lipid A. Lipid A modifiers associated with intrinsic cationic antimicrobial polypeptide (CAMP) resistance include ArnT, EptA, and the AlmEFG system. Whereas ArnT and EptA are prevalent across species, the AlmEFG tripartite machinery is restricted to the EI Tor biotype of V. cholerae O1. The newly discovered and rapidly evolving MCR family of enzymes are functionally unified in their catalytic action and consequent ability to confer colistin resistance. Polymyxins are a group of detergent-like antimicrobial peptides that are the ultimate line of defense against carbapenem-resistant pathogens in clinical settings. Polymyxin resistance primarily originates from structural remodeling of lipid A anchored on bacterial surfaces. We integrate genetic, structural, and biochemical aspects of three major types of lipid A modifiers that have been shown to confer intrinsic colistin resistance. Namely, we highlight ArnT, a glycosyltransferase, EptA, a phosphoethanolamine transferase, and the AlmEFG tripartite system, which is restricted to EI Tor biotype of Vibrio cholerae O1. We also discuss the growing family of mobile colistin resistance (MCR) enzymes, each of which is analogous to EptA, and which pose great challenges to global public health. Polymyxins are a group of detergent-like antimicrobial peptides that are the ultimate line of defense against carbapenem-resistant pathogens in clinical settings. Polymyxin resistance primarily originates from structural remodeling of lipid A anchored on bacterial surfaces. We integrate genetic, structural, and biochemical aspects of three major types of lipid A modifiers that have been shown to confer intrinsic colistin resistance. Namely, we highlight ArnT, a glycosyltransferase, EptA, a phosphoethanolamine transferase, and the AlmEFG tripartite system, which is restricted to EI Tor biotype of Vibrio cholerae O1. We also discuss the growing family of mobile colistin resistance (MCR) enzymes, each of which is analogous to EptA, and which pose great challenges to global public health. polymyxins, which are naturally produced by Paenibacillus polymyxa, are paradigmatic CAMP members. In addition, an endogenous CAMP represents a most ancient (and/or efficient) defense system in the context of host innate immunity. refers to the lipid A moiety linked to LPS, an important surface component of Gram-negative bacterium. Lipid A is a bis-phosphorylated derivative of β-1,6-linked D-glucosamine disaccharide with various types of fatty acyl chains in amide linkages. a growing body of MCR enzymes, the prototype being MCR-1, that can be transferred by diverse plasmids across enteric flora. a two-component signal transduction system regulating phenotypic polymyxin resistance, of which PmrA is a response regulator. a collection of integral membrane enzymes within the alkaline phosphatase superfamily. In general, they consist of a transmembrane domain and a soluble catalytic domain. The former domain anchors the enzyme to the periplasmic face of the cytoplasmic membrane.

Rumicidins are a family of mammalian host-defense peptides plugging the 70S ribosome exit tunnel

Ruminococcin C, an anti-clostridial sactipeptide produced by a prominent member of the human microbiota Ruminococcus gnavus

The unusual structure of Ruminococcin C1 antimicrobial peptide confers clinical properties

Ruminococcin C, a promising antibiotic produced by a human gut symbiont

Multimodal binding and inhibition of bacterial ribosomes by the antimicrobial peptides Api137 and Api88

Biosynthesis of the sactipeptide Ruminococcin C by the human microbiome: Mechanistic insights into thioether bond formation by radical SAM enzymes

Tetracenomycin X Inhibits Translation by Binding Within the Ribosomal Exit Tunnel

Mining Translation Inhibitors by a Unique Peptidyl-Aminonucleoside Synthetase Reveals Cystocin Biosynthesis and Self-Resistance

A Scalable Platform to Discover Antimicrobials of Ribosomal Origin

Inhibition of translation termination by the antimicrobial peptide Drosocin

Genome mining for ribosomally synthesized and post-translationally modified peptides (RiPPs) in anaerobic bacteria

Distant Ribose 2'-O-Methylation of 23S rRNA Helix 69 Pre-Orders the Capreomycin Drug Binding Pocket at the Ribosome Subunit Interface

Characterization of antibiotic resistance genes in the species of the rumen microbiota

Engineering ribosomally synthesized and posttranslationally modified peptides as new antibiotics

Novel Rapidly Diversifiable Antimicrobial RNA Polymerase Switch Region Inhibitors with Confirmed Mode of Action in Haemophilus Influenzae.

Ribosomal protein L17 functions as an antimicrobial protein in amphioxus

Genetic and Biochemical Mechanisms for Bacterial Lipid A Modifiers Associated with Polymyxin Resistance

Pathogen-encoded Rum DNA polymerase drives rapid bacterial drug resistance

Structural basis of Cfr-mediated antimicrobial resistance and mechanisms to evade it

Rule-based omics mining reveals antimicrobial macrocyclic peptides against drug-resistant clinical isolates

Novel BRICHOS-Related Antimicrobial Peptides from the Marine Worm Heteromastus filiformis: Transcriptome Mining, Synthesis, Biological Activities, and Therapeutic Potential